TY - JOUR
T1 - Effects of oral glutamine supplementation on exercise-induced gastrointestinal permeability and tight junction protein expression
AU - Zuhl, Micah N
AU - Lanphere, Kathryn R
AU - Kravitz, Len
AU - Mermier, Christine M
AU - Schneider, Suzanne
AU - Dokladny, Karol
AU - Moseley, Pope L
PY - 2014/1/15
Y1 - 2014/1/15
N2 - The objectives of this study are threefold: 1) to assess whether 7 days of oral glutamine (GLN) supplementation reduces exercise-induced intestinal permeability; 2) whether supplementation prevents the proinflammatory response; and 3) whether these changes are associated with upregulation of the heat shock response. On separate occasions, eight human subjects participated in baseline testing and in GLN and placebo (PLA) supplementation trials, followed by a 60-min treadmill run. Intestinal permeability was higher in the PLA trial compared with baseline and GLN trials (0.0604 ± 0.047 vs. 0.0218 ± 0.008 and 0.0272 ± 0.007, respectively; P < 0.05). IκBα expression in peripheral blood mononuclear cells was higher 240 min after exercise in the GLN trial compared with the PLA trial (1.411 ± 0.523 vs. 0.9839 ± 0.343, respectively; P < 0.05). In vitro using the intestinal epithelial cell line Caco-2, we measured effects of GLN supplementation (0, 4, and 6 mM) on heat-induced (37° or 41.8°C) heat shock protein 70 (HSP70), heat shock factor-1 (HSF-1), and occludin expression. HSF-1 and HSP70 levels increased in 6 mM supplementation at 41°C compared with 0 mM at 41°C (1.785 ± 0.495 vs. 0.6681 ± 0.290, and 1.973 ± 0.325 vs. 1.133 ± 0.129, respectively; P < 0.05). Occludin levels increased after 4 mM supplementation at 41°C and 6 mM at 41°C compared with 0 mM at 41°C (1.236 ± 0.219 and 1.849 ± 0.564 vs. 0.7434 ± 0.027, respectively; P < 0.001). GLN supplementation prevented exercise-induced permeability, possibly through HSF-1 activation.
AB - The objectives of this study are threefold: 1) to assess whether 7 days of oral glutamine (GLN) supplementation reduces exercise-induced intestinal permeability; 2) whether supplementation prevents the proinflammatory response; and 3) whether these changes are associated with upregulation of the heat shock response. On separate occasions, eight human subjects participated in baseline testing and in GLN and placebo (PLA) supplementation trials, followed by a 60-min treadmill run. Intestinal permeability was higher in the PLA trial compared with baseline and GLN trials (0.0604 ± 0.047 vs. 0.0218 ± 0.008 and 0.0272 ± 0.007, respectively; P < 0.05). IκBα expression in peripheral blood mononuclear cells was higher 240 min after exercise in the GLN trial compared with the PLA trial (1.411 ± 0.523 vs. 0.9839 ± 0.343, respectively; P < 0.05). In vitro using the intestinal epithelial cell line Caco-2, we measured effects of GLN supplementation (0, 4, and 6 mM) on heat-induced (37° or 41.8°C) heat shock protein 70 (HSP70), heat shock factor-1 (HSF-1), and occludin expression. HSF-1 and HSP70 levels increased in 6 mM supplementation at 41°C compared with 0 mM at 41°C (1.785 ± 0.495 vs. 0.6681 ± 0.290, and 1.973 ± 0.325 vs. 1.133 ± 0.129, respectively; P < 0.05). Occludin levels increased after 4 mM supplementation at 41°C and 6 mM at 41°C compared with 0 mM at 41°C (1.236 ± 0.219 and 1.849 ± 0.564 vs. 0.7434 ± 0.027, respectively; P < 0.001). GLN supplementation prevented exercise-induced permeability, possibly through HSF-1 activation.
KW - Administration, Oral
KW - Adult
KW - Caco-2 Cells
KW - Cell Line
KW - DNA-Binding Proteins/metabolism
KW - Dietary Supplements
KW - Epithelial Cells/drug effects
KW - Exercise/physiology
KW - Female
KW - Gastrointestinal Tract/drug effects
KW - Glutamine/administration & dosage
KW - HSP70 Heat-Shock Proteins/metabolism
KW - Heat Shock Transcription Factors
KW - Hot Temperature
KW - Humans
KW - I-kappa B Proteins/metabolism
KW - Intestinal Absorption/drug effects
KW - Leukocytes, Mononuclear/drug effects
KW - Male
KW - NF-KappaB Inhibitor alpha
KW - Tight Junction Proteins/metabolism
KW - Tight Junctions/drug effects
KW - Transcription Factors/metabolism
KW - Up-Regulation/drug effects
KW - Young Adult
U2 - 10.1152/japplphysiol.00646.2013
DO - 10.1152/japplphysiol.00646.2013
M3 - Journal article
C2 - 24285149
SN - 8750-7587
VL - 116
SP - 183
EP - 191
JO - Journal of Applied Physiology
JF - Journal of Applied Physiology
IS - 2
ER -